Related Experiment Video
Updated: Oct 10, 2025
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.6K
Neoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy
Lindy Davis1, Ashley Tarduno1, Yong-Chen Lu2,3
1Department of Surgery, Albany Medical Center, Albany, NY 12208, USA.
Cancers
|December 10, 2021
Summary
Checkpoint blockade immunotherapy and adoptive cell therapy show promise for metastatic cutaneous melanoma. Neoantigen recognition by T cells is key to anti-tumor responses and tumor regression in melanoma patients.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Metastatic cutaneous melanoma patients show significant responses to immunotherapy.
- Neoantigens, arising from tumor-specific mutations, are potential targets for T-cell-mediated anti-tumor immunity.
Purpose of the Study:
- To review the role of neoantigens in melanoma immunotherapy.
- To summarize current and ongoing clinical trials for cutaneous melanoma.
- To present evidence correlating neoantigen-reactive T cells with clinical responses.
Main Methods:
- Review of scientific literature on neoantigens and melanoma.
- Analysis of clinical trial data for checkpoint blockade immunotherapy and adoptive cell therapy.
- Examination of studies investigating T-cell responses to neoantigens.
Main Results:
- Neoantigen recognition by T cells is hypothesized as critical for anti-tumor responses.
- Evidence suggests a correlation between neoantigen-reactive T cells and clinical outcomes in melanoma immunotherapy.
- Ongoing clinical trials are refining treatment strategies for cutaneous melanoma.
Conclusions:
- Neoantigens are crucial players in the efficacy of T-cell-mediated anti-tumor responses in melanoma.
- Understanding neoantigen-reactive T cells can guide the development of more effective melanoma immunotherapies.
- Clinical trials are essential for advancing treatment paradigms in cutaneous melanoma.
Related Concept Videos
01:27Tumor Immunotherapy
723
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
723
02:17The Tumor Microenvironment
6.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K
01:22T Cell Activation and Clonal Selection
8.3K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
8.3K
01:27Cytotoxic T Cells-mediated Immune Response
4.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.2K
01:26Antigens Involved in Adaptive Immunity
774
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
774
02:38Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K